Hepatoblastoma · 5 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG AHEP0731 protocol H - non-responders Variant #01 Partial | — | R 5 215 | 21d | — | — | — | — | — |
COG AHEP0731 protocol H - responders Variant #01 Partial | — | R 5 215 | 21d | — | — | — | — | — |
COG AHEP0731 protocol W Variant #01 | — | R 2 776 | 21d | — | — | — | — | — |
SIOPEL-4 protocol, resectable after A3 Partial | — | — | — | — | — | — | — | — |
SIOPEL-4 protocol, unresectable after A3 Partial | — | — | — | — | — | — | — | — |
5 of 5 regimens shown